DRIO - DarioHealth Corp.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
12.45M
Enterprise Value 3
5.23M
Trailing P/E
N/A
Forward P/E 1
-1.14
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
1.67
Price/Book (mrq)
2.01
Enterprise Value/Revenue 3
0.70
Enterprise Value/EBITDA 6
-0.27

Trading Information

Stock Price History

Beta (3Y Monthly) 0.68
52-Week Change 3-68.91%
S&P500 52-Week Change 36.81%
52 Week High 31.3200
52 Week Low 30.2600
50-Day Moving Average 30.3465
200-Day Moving Average 30.5285

Share Statistics

Avg Vol (3 month) 394.52k
Avg Vol (10 day) 393.36k
Shares Outstanding 543.68M
Float 26.33M
% Held by Insiders 135.74%
% Held by Institutions 116.11%
Shares Short (Sep 30, 2019) 4257.95k
Short Ratio (Sep 30, 2019) 42.54
Short % of Float (Sep 30, 2019) 40.71%
Short % of Shares Outstanding (Sep 30, 2019) 40.59%
Shares Short (prior month Aug 30, 2019) 4211.09k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 218/1
Last Split Date 3Mar 4, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -265.04%
Operating Margin (ttm)-263.72%

Management Effectiveness

Return on Assets (ttm)-120.59%
Return on Equity (ttm)-386.46%

Income Statement

Revenue (ttm)7.47M
Revenue Per Share (ttm)0.22
Quarterly Revenue Growth (yoy)-19.80%
Gross Profit (ttm)1.76M
EBITDA -19.51M
Net Income Avi to Common (ttm)-19.8M
Diluted EPS (ttm)-0.5760
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.99M
Total Cash Per Share (mrq)0.18
Total Debt (mrq)786k
Total Debt/Equity (mrq)12.90
Current Ratio (mrq)1.89
Book Value Per Share (mrq)0.14

Cash Flow Statement

Operating Cash Flow (ttm)-16.17M
Levered Free Cash Flow (ttm)-8.95M